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Background: While combination antiretroviral therapy has extended the life expectancy of those infected with
human immunodeficiency virus (HIV), there is a high prevalence of comorbidities that increase the risk of
cardiovascular morbidity and mortality among people living with HIV/AIDS (PLWHA). The side effects associated
with antiretroviral therapy (ART) lead to multiple metabolic disorders, making the management of these metabolic
issues and risk of cardiovascular disease (CVD) in those treated with ART a critical issue. Clinical research trials,
primarily clinical exercise, rarely include this population due to unique challenges in research methods with
underserved minority populations living with a life threatening illness like HIV/AIDS. This paper describes the
rationale and design of a randomized clinical trial evaluating the feasibility of a home-based exercise program
designed to increase physical activity (PA) and reduce the risk of CVD in PLWHA.
Methods/design: PLWHA being treated with ART will be randomly assigned to one of two groups: a home-based
PA intervention or standard care. All participants will receive an educational weight loss workbook and pedometer
for self-monitoring of PA. Only those in the intervention group will receive additional elastic Thera-bands® for
strength training and behavioral telephone based coaching.
Discussion: This study will evaluate the feasibility of a home-based program designed to increase PA among
PLWHA. Further, it will evaluate the effectiveness of such a program to decrease modifiable risk factors for CVD as a
secondary outcome. This study was funded by the NIH/NINR R21 Grant 1R21NRO11281.
Trial registration: Clinical Trial Identifier NCT01377064
Keywords: Randomized trial, Cardiovascular disease, HIV, Physical activity, Self care, Study designBackground
People living with HIV/AIDS (PLWHA) are at an in-
creased risk for cardiovascular disease (CVD) once they
begin taking antiretroviral therapy (ART). Studies that
control for traditional CVD risk factors show a detri-
mental effect of ART on CVD risk in PLWHA. For ex-
ample, the incidence of myocardial infarction (MI)
increases directly with increased exposure to specific
ART regimens [1,2]. The majority of known side effects* Correspondence: jaggersj@mailbox.sc.edu
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reproduction in any medium, provided the orassociated with ART directly alter metabolic processes,
thus increasing the risk of metabolic syndrome. Symp-
toms of these side effects include lipodystrophy (abnor-
mal fat displacement), hyperlipidemia (i.e. triglycerides,
cholesterol), decreased HDL-C, and impaired fasting glu-
cose among others [3,4]. Similar symptoms are commonly
observed among people known to be at an increased risk
for CVD, diabetes, and other chronic diseases.
Extensive research has established the benefits of rou-
tine PA in the general population, including decreased
risk of CVD [5]. PA is an appropriate intervention for
reducing many modifiable risk factors of CVD, including
a number of those that are elevated with HIV infection
and/or treatment. Studies have shown that people of alll Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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diorespiratory fitness (CRF) [6]. These reductions have
been attributed to sedentary behavior and lifestyle habits.
Further, PLWHA often exhibit a maximal VO2 of 24% -
44% below their age-predicted normal values [6]. CRF, as
determined by a maximal VO2 test, is a powerful pre-
dictor of all-cause and CVD mortality[7,8] and of type 2
diabetes mellitus [9]. Short duration studies have shown
significant increases in CRF with moderate or high inten-
sity PA training in as little as 6 to 12 weeks as well as a
dose response to aerobic activity [6,10]. Other beneficial
physiological and anthropomorphic adaptations include
increased serum HDL-C, decreased triglycerides and total
cholesterol [11,12], and reduced BMI, waist-to-hip ratio,
and overall body fat [13]. Recent studies show that muscu-
lar strength is inversely associated with risk for metabolic
syndrome and all-cause mortality [14,15].
PA interventions that require regular attendance at a
facility are not ideal for populations that are more likely
to be financially disadvantaged, such as PLWHA, due to
barriers related to transportation, access, and cost. We
have used home-based PA programs successfully with
various populations [16-18]. These programs have tar-
geted healthy populations and those with heart failure,
cancer, sporadic inclusion body myositis (IBM), chronic
obstructive pulmonary disorder (COPD), and outcomes
associated with various inflammatory responses [19-22].
Other trials have focused on functional outcomes such
as the ability to complete tasks of daily living, or overall
cardiorespiratory fitness [23,24]. These programs incor-
porated moderate intensity PA, which has been proven
to be safe for clinical populations with functional limita-
tions [23,24]. Telephone delivered home-based interven-
tions have been found to be effective in promoting PA in
general populations of adults, and this intervention ap-
proach has been recommended for wider dissemination
[25]. The purpose of this paper is to describe the de-
tailed methods for a randomized clinical trial of a tele-
phone delivered home-based PA program designed to
increase physical activity and reduce the risk of CVD
in PLWHA.
Methods
This randomized clinical trial is being conducted to test
the effectiveness a 9-month home based PA interven-
tion. Further, we will examine the effects of routine PA
relative to a standard of care group. Physical and psy-
chological testing, as well as blood sampling, is being
performed on each participant at baseline, 18 weeks, and
36 weeks. Measurements will include either direct meas-
urement or measurement of surrogate markers/indices
for body composition, stress and health-related quality
of life, blood lipids and inflammatory markers, and glu-
cose metabolism.Description and selection criteria for participants
All participants were recruited between 2010–2012 from
one of two sites via physician reference or word of mouth;
the greater Columbia, South Carolina area or the Charles-
ton, South Carolina area. Study staff recruited underactive
men and women 18 years of age or older with a positive
HIV serostatus and on ART. Inclusion and exclusion cri-
teria for this study are shown in Table 1.
Participant screening
Figure 1 shows a flow chart of the study as participant’s
progress through, beginning with an initial telephone pre-
screening interview. Potential participants were asked gen-
eral eligibility questions regarding their age, HIV status,
current ART prescription, and telephone access over the
next 10 months. All eligible participants who wished to
learn more about the study were invited to a study orien-
tation session.
At the study orientation, a staff member gave a slide
presentation explaining the purpose of the study and study
expectations of participants. This presentation included
the participant responsibilities and potential health bene-
fits and risks related to study participation. Participants
were given an opportunity to ask questions about the
study and those who wished to participate signed an
informed consent approved by the University of South
Carolina’s Internal Review Board and completed further
questionnaires requesting contact and demographic infor-
mation. All eligible participants who signed the informed
consent were scheduled to take part in a run-in period.
During the run-in period participants were asked to
complete additional self-report questionnaires as de-
scribed below. Trained staff also obtained the following
standardized measurements: resting blood pressure,
height, weight, waist and hip circumference, and a fasted
blood draw. To avoid measurement error, each measure-
ment is obtained in triplicates with the average of the
two closest as the primary value used for data collection.
All participants are instructed not to eat or drink any-
thing except water at least 8 hours prior to their sched-
uled run-in visit. At the end of the session participants
were given a SenseWear® armband designed to measure
daily PA with oral and written instructions for proper
wear. Participants were instructed to wear the armband
at all times except while bathing or swimming until they
returned for baseline testing. The run-in activities serve
several purposes. First, wearing an armband allows par-
ticipants to better understand what type of activities
would be required in the study and to see if the partici-
pant would be compliant with attending multiple study
visits, as required by the trial. The goal is to screen out
participants unlikely to adhere to study requirements.
The second reason for including the run-in period and
session is to reduce participant burden at the orientation
Table 1 Inclusion/exclusion criteria
Inclusion criteria
• Age 18 years and older
• Medical diagnosis of HIV-1 positive serostatus
• Sedentary lifestyle: not actively exercising ≥ 3 d · wk-1 for 20 min per session
• Stable, DHHS-approved ART regimen for previous 3 months, with HIV viral load below 75 copies/mL
• Capable of performing the required exercise regimen
• Have daily access to a telephone for approximately 10 months
• Capacity and willingness to provide informed consent and accept randomized group assignment
Exclusion criteria Temporary exclusion criteria
• Individuals who have a clinical history strongly suggestive of
Type 1 diabetes.
• Total cholesterol ≥240 mg/dl with LDL-C ≥160 mg/dl or TG levels
≥300 mg/dl. Note: Individuals on cholesterol lowering medications
but meeting blood lipid requirements are eligible.
• History of serious arrythmias, cardiomyopathy, congestive heart failure,
stroke or transient ischemic cerebral attacks, peripheral vascular disease
with intermittent claudication, myocardial infarction, or CABG.
• Resting blood pressure >160 systolic and/or 90 diastolic.
Note: Individuals on blood pressure medications but meeting blood
pressure criteria are eligible.
• Malignancies in the past 5 years, except therapeutically controlled
skin cancer.
• HbA1c ≥11%. Individuals whose HbA1c exceeds this level will be
recommended to seek treatment immediately. Such individuals may
be re-screened after three months to re-assess HbA1c eligibility.
• Plans to be away > 4 weeks in the next 9 months. • Current opportunistic infection at the time of screening.
• Score of 5 or greater on the DAST or MAST
(signifying excessive use of drugs or alcohol).
• Participation in another intervention trial.
• Weight loss in excess of 10% body weight in previous 12 weeks. • Other temporary intervening event, such as sick spouse, bereavement,
or recent move.
• Chronic or recurrent respiratory, gastrointestinal, neuromuscular,
neurological, or psychiatric conditions.
• Inflammatory-related conditions such as collagen disorders.
• Any other medical condition or disease that is life-threatening
or that can interfere with or be aggravated by exercise.
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naires across multiple visits.
Participants returned for their baseline session 7–10
days after the run-in. At this time the armband was col-
lected and PA data was immediately uploaded into the
dataset. Participants are not provided with any data re-
trieved from the armband at this time. During this ses-
sion all participants completed a maximal exercise stress
test with a 12-lead ECG and breath by breath oxygen
analyzer. All tests were completed on a treadmill and su-
pervised by the study medical director. Following suc-
cessful completion of the exercise test and clearance for
participation by the medical director, study participants
were randomized.
Randomization
After successfully completing all screening visits (orien-
tation, run-in, and baseline assessment), eligible partici-
pants were randomized into 1 of 2 groups: standard care
or intervention. Both groups received an evidence-based
book on healthful eating and regular physical activity
[26] and a pedometer. Those randomized into the inter-
vention group received a one-on-one PA training session
to explain in further detail participant expectations anddemonstrate proper use of the elastic Thera-Bands® for
strength training. The physical activity education session
provides an overview of what constitutes physical activ-
ity, benefits of physical activity, different types of phys-
ical activity, current physical activity recommendations,
tips for starting a physical activity program and proper
use of the physical activity log. In addition to the educa-
tion session the health educator worked with each partici-
pant to help them establish reasonable short term goals
that would eventually lead up to a common long term goal
among the participants (≥ 150 minutes of routine PA per
week and 2–3 resistance training sessions per week).
Follow-up examinations
Participants are scheduled to return for a follow-up data
collection visit that occurs at 18- and 36- weeks after
randomization. The same measurements and question-
naires completed during the run-in session are assessed
during each follow-up visit. All sessions are completed
in the morning following an 8 hour fast. Participants are
also given the armband to wear for 7–10 days, with de-
tailed oral and written instructions for proper use. Partici-





















Figure 1 Study flow chart.
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The primary outcome of interest is physical activity, as
measured by the SenseWear® armband. These measure-
ments will be used as an index of program adherence aswell as a measure of total physical activity. Secondary
outcomes include physiological and psychological vari-
ables, such as cardiorespiratory fitness, adiposity and fat
distribution, full blood lipid panel, depression, anxiety,
stress, and health-related quality of life. Tertiary explora-
tory outcomes include assessment of serum CRP and IL-6.
Physical activity assessment
Physical activity will be assessed with the SenseWear®
armband, a commercially available (www.bodymedia.com)
lightweight physical activity monitor that is worn on the
upper left arm halfway between the acromion and olecra-
non processes. Using tri-accelerometry technology aug-
mented by 2 heat sensors (a thermistor-based skin surface
sensor and a proprietary heat flux sensor), and a galvanic
skin response sensor, the device is able to accurately mea-
sure and record total energy expenditure, and also mea-
sures activity intensity. These 4 internal sensors turn on
the monitor when detecting skin contact and measures
total time the armband was worn, daily energy expendi-
ture, step count, sleep efficiency, and the intensity, dura-
tion, and frequency of physical activity bouts. All armband
data will be analyzed by computer-based software using
demographic information (gender, age, height, and weight
at prior assessment) and proprietary algorithms.
Validity of SenseWear armband
Validity of armband energy expenditure estimates has
been reported in several conditions including resting,
exercise (ie treadmill and cycle ergometry), and free-
living conditions (ie physical activity and exercise) [27-29].
St-Onge et al. found that when comparing the armband to
doubly labeled water daily energy expenditure had an
interclass correlation of 0.81 (P < 0.01) between the two
methods [30]. When comparing the armband to the Intel-
ligent Device for Estimating Energy Expenditure and Ac-
tivity (IDEEA) Welk et al. showed comparable results
between the armband and IDEEA when estimating energy
expenditure and PA [29].
Intervention
Components and approach
Two interventionists were trained by a clinical psycholo-
gist with expertise in behavioral interventions to imple-
ment the Active Choices program (developed at Stanford
University). Active Choices is a home-based physical ac-
tivity program that uses theoretically-based strategies to
help participants make lifestyle changes. Active Choices is
based on both social cognitive theory [31] and the
transtheoretical model [32]. The intervention begins with
a 60-minute individual face-to-face session in which rap-
port was established; the program and expectations are
described; a PA and diet history is taken; realistic, specific,
and measurable short-term and long-term goals are set;
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pedometer is given; self-monitoring tools (pedometer and
log) are distributed; and a schedule for follow-up tele-
phone calls is set.
The face-to-face session will be followed by regular
telephone counseling calls (15–20 minutes each). During
the initial adoption phase (weeks 1–8) participants will
receive telephone calls once a week. After the adoption
phase, participants will enter a transition phase (weeks
9–26) during which participants received a telephone
call every other week. The goal for the transition phase
is for the participants to work up to 150 minutes of
moderate- intensity physical activity and complete two
resistance training sessions. Following the transition
phase, participants begin a maintenance phase (weeks 27
to the end of the trial) where they will continue to re-
ceive a telephone call every other week. The exercise
regimens of weekly 150 minutes of moderate-intensity
PA and 2 resistance training sessions will also continue.
Although the Active Choices program recommends two
calls per month during the first two months and one call
per month thereafter, we believe that more regular con-
tact is important with PLWHA. We anticipate that par-
ticipants in our trial will be predominantly financially
disadvantaged, have many challenges to changing behav-
ior, and would benefit from additional support. More
frequent contact also allows us to monitor participant
health and safety.
Each call will begin with a review of goals (cognitive or
behavioral) set on the last call, assessment of current
health and medical status and changes in status, and ac-
tual physical activity participation since the last call (type
of activities and total time spent doing each activity).
Participants will be encouraged to discuss barriers to
change (and the interventionist helped to engage the
participant in problem solving skills) as well as suc-
cesses. The participant’s stage of readiness for change
will be assessed and this information, along with infor-
mation learned about barriers and successes on previous
calls help to guide the selection of counseling topics/strat-
egies for the call. For example, discussion of a cognitive
strategy such as becoming more aware of the benefits of
PA could be used for participants in precontemplation or
contemplation, whereas a behavioral strategy such as
enlisting social support could be discussed for participants
in later stages of change (preparation, action, mainten-
ance). The interventionist will be provided a list of call
topics (i.e., cognitive or behavioral strategies and ap-
proaches that map onto the two theories) most appropri-
ate for each stage of change. Over the course of the
intervention, the interventionist will be encouraged to
choose and discuss multiple call strategies that are most
relevant for the participant. Calls typically end with the
interventionist helping the participant select cognitive orbehavioral goals for the next one to two weeks and
discussing ways to overcome barriers that may get in the
way of these goals. The interventionist may send a “tip
sheet” if they feel that participant needs additional infor-
mation (e.g., exercising during the heat).
Frequent self-monitoring of physical activity, diet, and
weight will be strongly encouraged, as self-monitoring is
positively associated with behavioral adherence (32). A
pedometer will be used as a motivation and self-
monitoring tool. The health counselor will use minutes
per day of physical activity as part of goal setting activ-
ities (e.g., focusing on increasing weekly physical activity
time through 10-minute or more bouts of walking).
Non-exercise standard care group Since randomiza-
tion occurred after the run-in period, the participants in
the standard care group received the same educational
material and weight loss manual just as those random-
ized to the PA group. Physical activity habits will be
monitored throughout the study for participants ran-
domized to the standard care group in the same manner
as for the intervention group using the SenseWear® arm-
band. One potential problem in this group is the possi-
bility of participants losing interest in the study because
they are assigned to a “control” group. We have been
successful in reducing standard care group dropout in
previous studies by maintaining telephone contact with
standard care group participants. In this study, we will
contact the standard care group participants by tele-
phone every two weeks to update health status, maintain
current contact information, and emphasize the import-
ance of their participation for a successful study.
Testing procedures
Graded exercise stress test
Following a medical examination including evaluation of
family and personal medical history, resting blood pres-
sure, and resting ECG evaluation, each participant com-
pleted a graded exercise stress treadmill test (GXT). The
GXT is used to screen for abnormal physiological re-
sponses to exercise, including blood pressure and ECG
responses, and for determining the participant’s current
level of cardiorespiratory fitness. The test is terminated
either at volitional exhaustion or at observation of ab-
normal responses that are contraindications for exercise.
This test has been found to be highly reproducible with
a high sensitivity to changes in VO2 peak [33].
Body mass index and visceral fat
Anthropomorphic measurements are made using stand-
ard laboratory equipment. Height and weight will be
used to determine body mass index (BMI, weight in kg/
height in meters2) as an index of total body fat. Waist
circumference (WC) is measured as an index of visceral
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visceral fat, but budget constraints preclude more direct
measurement of visceral fat. Nevertheless, combined use
of BMI and waist circumference has been shown to be a
good predictor of mortality [34].
Laboratory assays from blood products
Blood sampling
Blood draws are performed following an 8 hour fast.
Participants will be asked to refrain from taking aspirin
and other anti-inflammatory medications for 48 hours
prior to the blood draw. Twenty milliliters of whole ven-
ous blood will be drawn into standard vacutainer tubes
by trained personnel. Standard separation procedures
will be used for collection of serum and plasma. Samples
will be stored at −80°C until future analysis.
Blood analysis
The blood components of interest will be measured in
duplicate by LabCorp® clinical trials division. All samples
are being analyzed by a LabCorp professional at a central
location that undergoes rigorous quality assurance testing
to deliver high accuracy and reliability in the results.
Self-report questionnaires
Drug abuse screening test (DAST)
The DAST is a 28-item self-report questionnaire that
provides quantitative index of problems related to drug
misuse [35]. The DAST has been validated with an in-
ternal consistency of .92 [35]. A score of 6 or greater is
suggestive of significant drug misuse which was used as
part of the exclusion criteria.
Michigan alcohol screening test (MAST)
The MAST is a 25-item self-report questionnaire that
provides rapid and effective screening for alcohol-related
problems and alcoholism. Test-retest reliability for the
MAST has been reported as .84 [36], however, Boyd
reported a reliability of .94 in rural women substance
abusers [36]. A score of 5 or greater is suggestive of sig-
nificant alcohol dependency which was used as part of
the exclusion criteria.
Sociodemographic data
Sociodemographic characteristics was obtained to pro-
vide a description of the participants in the study and to
assess the generalizability of the results. Variables in-
clude age, gender, race, income, educational level, em-
ployment and marital status, as well as the number of
children living in the household and previous medical
conditions. Additionally, information was collected from
the participants to describe the usual care (pharmaco-
logical and psychological) they receive to control this as
a potential confounder.Medication
Because medication use and change in medications
could be a confounding factor, all medications will be
recorded by self-report, including drug name and spe-
cific dosage, at the 0, 18, and 36 week time points. Medi-
cation changes that are determined to be significant will
be included as covariates during data analysis, however
changes in medications will not exclude or drop the par-
ticipants from the study.
Perceived stress scale (PSS)
The 10-item PSS assesses the degree to which an indi-
vidual finds life events unpredictable, uncontrollable, or
overwhelming [37]. Internal consistency has been dem-
onstrated by a Cronbach’s alpha of 0.78 [37]. Validity of
the PSS is supported by significant correlations with
greater help-seeking, poorer health, more health service
utilization, and poorer life satisfaction [37].
MOS 36-item short-form health survey (SF-36)
The SF-36 is a widely-used and validated self-report
measure of health-related quality of life [38,39]. It con-
sists of eight health concepts including physical function,
social function, pain, mental health, energy/fatigue, gen-
eral health perceptions, role limitations due to physical
problems, and role limitations due to emotional prob-
lems. The SF-36 can be divided into the two parts: the
Mental Composite Score (MCS) and the Physical Com-
posite Score (PCS). The internal consistency reliability
coefficients are high for its eight scales and ranges from
0.78 to 0.93 [40].
Centers for epidemiologic studies-depression (CES-D)
The 20-item CES-D is a widely-used and validated self-
report measure of depressive symptoms [41,42]. Compo-
nents of the CES-D include depressed mood, feelings of
guilt and worthlessness, feelings of hopelessness and
helplessness, psychomotor retardation, loss of appetite,
and sleep disturbance. The CES-D has a high internal
consistency in both the general population (.85) and in
patient populations (.90) [41].
Theory-based measures
Several self-report measures were chosen to measure the
theoretical constructs which form the basis of our inter-
vention. These measures will allow us to examine whether
the intervention changed constructs that are proposed by
social cognitive theory and the transtheoretical model to
be mediators of change. While it would be ideal to collect
data on all of the constructs from these two theories, we
have selected to focus on those most widely used in inter-
vention studies in order to reduce participant burden.
The Self-Efficacy for Exercise Questionnaire consists
of 14 items that ask participants to rate their confidence
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faced with commonly-cited barriers (e.g., when tired,
depressed, have a lot of work to do, etc.) [43]. This ques-
tionnaire has been shown to be valid and reliable across
race, education, gender, and weight categories [44]. In-
ternal consistency was high for all subgroups (α = .90
to .94) and criterion-related validity was established
across subgroups.
Social support for PA will be assessed with a commonly-
used 13-item scale developed by Sallis and colleagues
[45]. This scale has show acceptable test-retest reliability
(r = 0.55 to 0.86) and internal consistency (α = 0.61 to 0.91),
as well as concurrent criterion-related validity [45].
Self-regulatory behavior will be assessed with a 20-
item scale that assesses the degree to which participants
self-monitor, set goals, and problem solve [46]. The mea-
sure has been shown to have high internal consistency
(α = .89 for goals, .87 for plans) and strong associations
with PA [46].
Decisional balance will be assessed with a commonly
used 16-item (10 pros, 6 cons) scale developed by Marcus
and colleagues [47]. This scale has shown acceptable in-
ternal consistency (α = 0.79 for cons; 0.95 for cons) and
significant associations with stage of readiness for change.
Finally, the five cognitive and 5 behavioral processes of
change will be measured with a commonly-used 20-item
scale (2 items for each process) developed by Marcus
and colleagues [48]. Factor analysis has revealed two
higher order constructs (cognitive/experiential and be-
havioral processes), and those in early stages of change
report greater use of cognitive processes and less use of
behavioral processes, and vice versa for those in later
stages [48].
Statistical analysis
Descriptive baseline characteristics for group compari-
sons will be tabulated as means and standard deviations
(SD) or as percentages. Differences between the two
groups in the primary outcome will be tested according
to the intention-to-treat philosophy. All randomized par-
ticipants will be analyzed according to their group as-
signment at randomization, regardless of adherence to
the intervention. The primary comparison is the differ-
ence in the amount of moderate-intensity physical activ-
ity between the intervention group and the standard
care group at 18 and 36 weeks of the intervention, re-
spectively. Secondary, tertiary, and exploratory analyses
will focus on the other outcomes and subgroups, and
findings will be interpreted cautiously. All analyses will
take into account pre-specified covariates, including age,
gender, race, education, smoking status, response sets,
medication changes, and baseline values of outcome mea-
sures. Analyses of continuous outcome measures will be
based on analysis of covariance (ANCOVA) models of 18-and 36-month change scores since baseline and treatment
effects will be summarized as least-squares adjusted
means [49]. Analysis of binary outcomes will be based on
logistic regression, and analyses of ordered polytomous
outcomes will be based on ordered logit proportional-
odds models [50]. The potential effects of missing data
will be explored under various models for nonignorable
missing data mechanisms, and through multiple imput-
ation models under ignorable missing data assumptions
[51]. An α level of 0.05 will be used to indicate statistical
significance.
Power calculation
For a feasibility study, power is not a major consider-
ation. However, being able to detect moderately large
differences between groups is reasonable. Assuming a
Type I error rate of α = 0.10 and 80% power, we can de-
tect a difference between the intervention and control
groups in the change in PA of 0.55 standard deviation
units. That is, if the standard deviation of accelerometry-
based PA is 120 min/week MPA and the pre-post correl-
ation is 0.4, we can detect a difference of 80 minutes/
week. A major goal of this study is to generate data to
inform development of a larger randomized trial of this
community-based PA intervention. The data will there-
fore be used to generate descriptive statistics (means and
standard deviations) for the various physiological risk
factors for cardiovascular disease and their correspond-




Figure 1 shows the flow of participants through the re-
cruitment and randomization phase of the study. A total
of 95 phone screenings were conducted, of which 84
were considered eligible after preliminary screening and
invited to attend the orientation session. The most com-
mon reason for ineligibility following the phone screen
included not currently on ART. Of those invited to at-
tend the orientation session, 8 were no shows and could
not be re-scheduled, 2 were found ineligible, and 74
were scheduled to return for the run-in visit for further
data collection. The total number of participants who
attended the run-in session was 72, with 2 no shows, in
which all who attended were invited to the final baseline
session. Prior to randomization, but after the baseline
measurement was conducted, 3 participants (4%) were
further excluded due to uncontrollable hypertension
which is a contraindication to exercise testing. Any par-
ticipant unable to complete the graded exercise test was
not cleared for study participation by the medical super-
visor. Thus, 94% of those consented and measured at
baseline were randomized to an intervention condition.
Table 2 Baseline characteristics of participants
Characteristic Intervention (n = 34) Control (n = 34) Total (n = 68)
Gender, % (n)
Male 47.1 (16) 44.1 (15) 45.6 (31)
Female 52.9 (18) 55.9 (19) 54.4 (37)
Race, % (n)
White 14.7 (5) 8.8 (3) 11.8 (8)
Black/African American 79.4 (27) 85.3 (29) 82.4 (56)
>1 category 2.9 (1) 2.9 (1) 2.9 (2)
Hispanic ethnicity, % (n)
Yes 2.9 (1) 5.9 (2) 4.4 (3)
No 97.1 (33) 94.1 (32) 95.6 (65)
Age in years, Mean ± SD 49 ± 11 48 ± 10 48 ± 10
Education, % (n)
Never attended school 0 0 0
Grades 1-8 0 0 0
Grade 9-11 14.7 (5) 14.7 (5) 14.7 (10)
Grade 12 or GED 23.5 (8) 26.5 (9) 25.0 (17)
Some college 38.2 (13) 44.1 (15) 41.2 (28)
College grad 23.5 (8) 14.7 (5) 19.1 (13)
Maritial status, % (n)
Married 8.8 (3) 11.8 (4) 10.3 (7)
Divorced 23.5 (8) 11.8 (4) 17.6 (12)
Widowed 5.9 (2) 8.8 (3) 7.4 (5)
Separated 11.8 (4) 11.8 (4) 11.8 (8)
Never married 47.1 (16) 32.4 (11) 39.7 (27)
Couple/Significant Other 2.9 (1) 23.5 (8) 13.2 (9)
Employment status, % (n)
Employed 29.4 (10) 44.1 (15) 36.7 (25)
Not employed 35.3 (12) 20.6 (7) 28.0 (19)
Student 2.9 (1) 5.9 (2) 4.4 (3)
Retired 2.9 (1) 2.9 (1) 2.9 (2)
Unable to work 29.4 (10) 20.6 (7) 25.0 (17)
Income, % (n)
$0-9,999 29.4 (10 35.3 (12) 32.4 (22)
$10,000- 19,999 26.5 (9) 20.6 (7) 23.5 (16)
$20,000- 29,999 14.7 (5) 11.8 (4) 13.2 (9)
$30,000- 39,999 5.9 (2) 17.6 (6) 11.8 (8)
$40,000- 49,999 2.9 (1) 2.9 (1) 2.9 (2)
$50,000- 59,999 0 2.9 (1) 1.5 (1)
Prefer not to say 20.6 (7) 8.8 (3) 14.7 (10)
Children in household, % (n)
0 85.3 (29) 76.5 (26) 80.9 (55)
1 2.9 (1) 11.8 (4) 7.4 (5)
2 5.9 (2) 5.9 (2) 5.9 (4)
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Table 2 Baseline characteristics of participants (Continued)
3 0 2.9 (1) 1.5 (1)
≥ 4 5.9 (2) 0 3 (2)
Weight in pounds, Mean ± SD 191.48 ± 58.59 192.14 ± 49.38 191.81 ± 53.76
BMI (kg/m2), Mean ± SD 30.04 ± 8.38 30.79 ± 7.90 30.42 ± 8.09
Waist circumference, Mean ± SD 98.74 ± 20.96 99.22 ± 18.54 98.98 ± 19.63
Blood Pressure, Mean ± SD
Systolic (mmHg) 127 ± 16 130 ± 14 128 ± 15
Diastolic (mmHg) 83 ± 10 83 ± 10 83 ± 10
Self-reported conditions %(n)
Heart condition
Yes 0 0 0
No 100 (34) 100 (34) 100 (68)
Cancer
Yes 2.9 (1) 8.8 (3) 6 (4)
No 97.1 (33) 91.2 (31) 94 (64)
Diabetes
Yes 5.8 (2) 20.6 (7) 13.2 (9)
No 94.2 (32) 79.4 (27) 86.8 (59)
High Cholesterol
Yes 36.4 (12) 33.3 (11) 34.8 (23)
No 63.6 (21) 66.7 (22) 65.2 (43)
Hypertension
Yes 45.5 (15) 48.5 (16) 47 (31)
No 54.5 (18) 51.5 (17) 53 (35)
Sleep apnea
Yes 17.6 (6) 6.1 (2) 11.9 (8)
No 82.4 (28) 93.9 (31) 88.1 (59)
Arthritis
Yes 20.6 (7) 12.1 (4) 16.4 (11)
No 79.4 (27) 87.9 (29) 83.6 (56)
Hepatitis C
Yes 17.6 (6) 15.6 (5) 16.7 (11)
No 82.4 (28) 84.4 (27) 83.3 (55)
Fasting blood analysis, Mean ± SD
Cholsterol (mg/dL) 188.89 ± 52.92 186.59 ± 38.55 187.76 ± 46.01
Triglycerides (mg/dL) 156.39 ± 146.87 130.59 ± 84.44 143.73 ± 119.95
LDL (mg/dL) 109.56 ± 35.98 107.41 ± 36.68 108.48 ± 36.00
HDL (mg/dL) 45.86 ± 20.58 52.96 ± 24.60 49.35 ± 22.71
VLDL (mg/dL) 26.19 ± 11.14 26.22 ± 16.90 26.20 ± 14.17
Glucose (mg/dL) 106.93 ± 48.22 111.33 ± 34.41 109.09 ± 41.69
C-Reactive Protein (mg/L) 4.76 ± 5.53 5.49 ± 5.96 5.12 ± 5.70
Interleukin-6 (pg/mL) 5.16 ± 7.11 4.07 ± 1.95 4.55 ± 4.88
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Demographic and health-related baseline characteristics
of the study sample are presented in Table 2. Interven-
tion and Control participants did not differ significantly
(p > 0.05) on any characteristic at baseline. Most of the
participants self-identified as African-American (82.4%)
and female (54.4%). The average age was 40 years and
most participants were either singe/never married
(39.7%) or divorced (17.6%). Although majority have
some college education (41.2%), only 19% of the study
participants have a college degree and more than half
are out of work by self-identifying as either unemployed
(28%) or unable to work (25%).
Discussion
While combination antiretroviral therapy has dramatic-
ally extended the life expectancy of those infected with
human immunodeficiency virus (HIV), there is a high
prevalence of comorbidities that increase the risk of car-
diovascular morbidity and mortality in the general popu-
lation, and people living with HIV/AIDS (PLWHA)
[52,53]. The side effects associated with antiretroviral
therapy (ART) lead to multiple metabolic disorders,
making the management of these metabolic issues and
risk of cardiovascular disease (CVD) in those treated
with ART a critical issue. Studies indicate that even rela-
tively modest increases in physical activity (PA) can in-
crease cardiorespiratory fitness, reduce visceral fat and
increase muscle mass, reduce serum total and LDL/
VLDL cholesterol and triglycerides, and increase serum
HDL cholesterol within the general population [54-56],
and similar results have begun to emerge in regards to
PLWHA [57,58]. Due to the low socio-economic status
of this particular population it is extremely important
that a feasible and cost-effective program be imple-
mented, such as routine physical activity, to help them
manage the metabolic complications associated with
ART. This study will evaluate a telephone delivered
home-based PA program designed to increase PA among
PLWHA. Further, it will evaluate the effectiveness of
such a program to decrease modifiable risk factors for
CVD as a secondary outcome. To our knowledge there
are no data available on the outcomes, in terms of either
program adherence or risk factor reduction, of a home-
based PA/exercise training program when prescribed to
PLWHA. This gap in knowledge regarding home-based
training for community-dwelling patients is of special
concern considering the disproportionate prevalence of
HIV infection in poor, rural, and minority populations
who have limited access to exercise training facilities
and professional support.
PA has been shown in center-based clinical trials to re-
duce CVD risk factors in PLWHA and home-based PA
programs have produced benefits in numerous clinicaland healthy populations. This study will allow us to test
methods and collect process evaluation data with the
goal of disseminating an effective approach to increasing
PA levels to reduce CVD risk in PLWHA. A secondary
goal of this study is to provide a preliminary assessment
of activity-induced changes to CVD risk factors includ-
ing cardiorespiratory fitness, blood lipids and markers of
systemic inflammation. Currently this study is in the
final stages of data collection. All participants have been
recruited and randomized.
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